Adverse Outcome Pathway on antagonist binding to PPARα leading to body-weight loss:

The present AOP describes antagonistic chemical binding to the peroxisome proliferator-activated receptor α (PPARα), resulting in preferential binding a co-repressor to the overall PPARα signalling complex causing a chain of events that includes: antagonism of PPARα nuclear signalling, decreased tra...

Full description

Saved in:
Bibliographic Details
Main Author: Gust, Kurt A.. (Author)
Other Authors: Wilbanks, Mitchell S.. (Contributor), Collier, Zachary A.. (Contributor), Burgoon, Lyle D.. (Contributor)
Format: Electronic eBook
Language:English
Published: Paris OECD Publishing 2019
Series:OECD Series on Adverse Outcome Pathways
Subjects:
Online Access:Volltext
Summary:The present AOP describes antagonistic chemical binding to the peroxisome proliferator-activated receptor α (PPARα), resulting in preferential binding a co-repressor to the overall PPARα signalling complex causing a chain of events that includes: antagonism of PPARα nuclear signalling, decreased transcriptional expression of PPARα-regulated genes that support energy metabolism, inhibited metabolic energy production (decreased fatty acid beta oxidation and ketogenesis), and increase in catabolism of muscle protein, culminating with starvation-like weight loss. The AOP is likely to be synergised during fasting, starvation or malnutrition events. The adverse outcome of this AOP is body-weight loss, which within the context of dynamic energy budget theory, decreases energy allocations to organismal maturation and reproduction and has been demonstrated to negatively affect ecological fitness
Physical Description:1 Online-Ressource (83 Seiten)
DOI:10.1787/29d4e08d-en

There is no print copy available.

Interlibrary loan Place Request Caution: Not in THWS collection! Get full text